Literature DB >> 18434652

Artesunate for the treatment of severe falciparum malaria.

Philip J Rosenthal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18434652     DOI： 10.1056/NEJMct0709050

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  43 in total

1.  Evaluation of three medicinal plant extracts against Plasmodium falciparum and selected microganisms.

Authors:  Abiodun Falodun; Vincent Imieje; Osayewenre Erharuyi; Joy Ahomafor; Melissa R Jacob; Shabana I Khan; Mark T Hamann
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-06-04

Review 2.  Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.

Authors:  Margaret A Phillips; Pradipsinh K Rathod
Journal:  Infect Disord Drug Targets       Date:  2010-06

3.  In vitro evaluation of aliphatic fatty alcohol metabolites of Perseaamericana seed as potential antimalarial and antimicrobial agents.

Authors:  A Falodun; O Erharuyi; V Imieje; J Ahomafor; C Akunyuli; M Jacobs; S Khan; M T Hamann; P Langer
Journal:  Niger J Biotechnol       Date:  2014

4.  Combined intravenous treatment with artesunate and quinine for severe malaria in Italy.

Authors:  Alessandro Bartoloni; Lina Tomasoni; Filippo Bartalesi; Luisa Galli; Spartaco Sani; Sara Veloci; Lorenzo Zammarchi; Alessandro Pini; Francesco Castelli
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

5.  Symmetrical peripheral digital gangrene following severe Plasmodium falciparum malaria-induced disseminated intravascular coagulopathy.

Authors:  Sana Z A Ghafoor; Eva A MacRae; Keith G Harding; Girish K Patel
Journal:  Int Wound J       Date:  2010-10       Impact factor: 3.315

6.  Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.

Authors:  Ramesh Gujjar; Alka Marwaha; Farah El Mazouni; John White; Karen L White; Sharon Creason; David M Shackleford; Jeffrey Baldwin; William N Charman; Frederick S Buckner; Susan Charman; Pradipsinh K Rathod; Margaret A Phillips
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

7.  Activation-induced T helper cell death contributes to Th1/Th2 polarization following murine Schistosoma japonicum infection.

Authors:  Xinyu Xu; Xiaoyun Wen; Ying Chi; Lei He; Sha Zhou; Xuefeng Wang; Jiaqing Zhao; Feng Liu; Chuan Su
Journal:  J Biomed Biotechnol       Date:  2010-01-13

8.  Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.

Authors:  Patricia A Reis; Clarissa M Comim; Fernanda Hermani; Bruno Silva; Tatiana Barichello; Aline C Portella; Flavia C A Gomes; Ive M Sab; Valber S Frutuoso; Marcus F Oliveira; Patricia T Bozza; Fernando A Bozza; Felipe Dal-Pizzol; Guy A Zimmerman; João Quevedo; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

9.  Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.

Authors:  Desmond Slade; Ahmed M Galal; Waseem Gul; Mohamed M Radwan; Safwat A Ahmed; Shabana I Khan; Babu L Tekwani; Melissa R Jacob; Samir A Ross; Mahmoud A Elsohly
Journal:  Bioorg Med Chem       Date:  2009-10-30       Impact factor: 3.641

10.  Artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria.

Authors:  Stephan Ehrhardt; Christian G Meyer
Journal:  Ther Clin Risk Manag       Date:  2009-10-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.